Authors: Myatt, N Aristodemou, P Neale, MH Foss, AJE Hungerford, JL Bhattacharya, S Cree, IA

Citation: N. Myatt et al., Abnormalities of the transforming growth factor-beta pathway in ocular melanoma, J PATHOLOGY, 192(4), 2000, pp. 511-518

Authors: Satherley, K de Souza, L Neale, MH Alexander, RA Myatt, N Foss, AJE Hungerford, JL Hickson, ID Cree, IA

Citation: K. Satherley et al., Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma, J PATHOLOGY, 192(2), 2000, pp. 174-181

Authors: Chana, JS Wilson, GD Cree, IA Alexander, RA Myatt, N Neale, M Foss, AJE Hungerford, JL

Citation: Js. Chana et al., c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma, BR J OPHTH, 83(1), 1999, pp. 110-114

Authors: Neale, MH Myatt, N Cree, IA Kurbacher, CM Foss, AJE Hungerford, JL Plowman, PN

Citation: Mh. Neale et al., Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside, BR J CANC, 79(9-10), 1999, pp. 1487-1493